3.8 Review

The NG2 proteoglycan: Past insights and future prospects

Journal

JOURNAL OF NEUROCYTOLOGY
Volume 31, Issue 6-7, Pages 423-435

Publisher

SPRINGER
DOI: 10.1023/A:1025731428581

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA95287] Funding Source: Medline
  2. NIAMS NIH HHS [R01 AR44400] Funding Source: Medline
  3. NICHD NIH HHS [P01 HD25938] Funding Source: Medline
  4. NINDS NIH HHS [R01 NS21990, R01 NS32767] Funding Source: Medline

Ask authors/readers for more resources

The NG2 chondroitin sulfate proteoglycan is a valuable marker for several types of incompletely-differentiated precursor cells, including oligodendrocyte progenitors in the central nervous system, developing mesenchymal cells in cartilage, muscle, and bone, and pericytes/smooth muscle cells in developing vasculature. In addition to extending our knowledge about the developmental roles of these cell types, current studies on NG2 are also providing information about the molecular mechanisms through which the proteoglycan itself influences progenitor development. This research suggests that interaction of NG2 with extracellular and intracellular ligands regulates signaling events that are important for both cell proliferation and cell migration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available